⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Archana ShendeM D

Family Practice · Anaheim, CA 92801

NPI: 1043255938

Share:

23

🟡 Moderate

Risk Flags

Elevated long-acting opioid rateElevated antipsychotic prescribing (65+)Opioid + benzodiazepine co-prescriberHigh fills per patient

Risk indicators are statistical patterns, not allegations. Learn more

10,446

Total Claims

$1.8M

Drug Cost

466

Beneficiaries

$3,951

Cost/Patient

Risk Score Breakdown 23/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid + benzodiazepine combo+8
Elderly antipsychotic prescribing+5
Long-acting opioid rate+4
High fills per patient+3

Score components are additive. Read full methodology

Peer Comparison vs. 106,889 Family Practice providers

-73%

Opioid rate vs peers

0.7% vs 2.6% avg

+270%

Cost per patient vs peers

$3,951 vs $1,068 avg

+87%

Brand preference vs peers

16.9% vs 9.0% avg

⚠️ Opioid + Benzodiazepine Co-Prescriber

This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.

🔎 Data Overview

⚠️

This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

0.7%

Opioid Rate

72

Opioid Claims

$14K

Opioid Cost

18.1%

Long-Acting Rate

Brand vs Generic

83% generic

Brand: 1,738 claims · $1.5M

Generic: 8,573 claims · $313K

Top Prescribed Drugs

Drug (Generic)ClaimsCost
Sitagliptin Phosphate92$118K
Apixaban100$110K
Dulaglutide76$105K
Empagliflozin70$89K
Sacubitril/Valsartan90$78K
Mirabegron73$67K
Semaglutide43$59K
Rivaroxaban68$58K
Bempedoic Acid/Ezetimibe52$50K
Fluticasone/Umeclidin/Vilanter59$48K
Icosapent Ethyl49$46K
Denosumab26$44K
Semaglutide32$41K
Linagliptin52$39K
Dapagliflozin Propanediol37$34K

Prescribing Profile

160

Unique Drugs

$487K

IRA Negotiated Drugs

$204K

GLP-1 Drugs

23.0

Anomaly Score

Patient Profile

76

Avg Age

73%

Female

1.60

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data